BAC Water Concentration Calculations for Peptide Research: Step-by-Step | Palmetto Peptides

BAC Water Concentration Calculations for Peptide Research: A Step-by-Step Reference

Research Notice: This article covers research topics relevant to BAC Water — available from Palmetto Peptides for laboratory use only.

Research Use Only Disclaimer: All peptides listed on this page are sold exclusively for in vitro and legitimate laboratory research purposes. They are not intended for human consumption, veterinary use, or any clinical application. The information in this article is for scientific and educational reference only and does not constitute medical advice. All research use must comply with applicable federal, state, and institutional regulations. Palmetto Peptides complies fully with all applicable FDA guidelines.

DISCLAIMER: This article is for educational and scientific research reference purposes only. All compounds discussed are not approved by the FDA for use in humans or animals. All data discussed here reflects preclinical animal research or laboratory use. Palmetto Peptides sells these compounds exclusively for in vitro and preclinical laboratory research. Nothing in this article constitutes medical advice.

For background on this topic, see the Complete Guide to BAC Water for Peptide Research from Palmetto Peptides.

Last Updated: May 14, 2026 | Reading Time: Approximately 10 minutes | Author: Palmetto Peptides Research Team

Quick Answer

To calculate peptide concentration after reconstitution, divide the total mass of peptide (in milligrams) by the volume of BAC water added (in milliliters) to get the concentration in mg/mL. For example, dissolving 5 mg of peptide in 2 mL of BAC water yields a 2.5 mg/mL solution. From there, all downstream volume calculations follow from this stock concentration using the dilution formula C₁V₁ = C₂V₂.

Why Accurate Concentration Calculations Matter in Peptide Research

Concentration math is the foundation of reproducible peptide research. A miscalculation at the reconstitution stage propagates through every subsequent aliquot, dilution, and experimental comparison. If a researcher prepares a stock solution at 2 mg/mL believing it to be 1 mg/mL, every downstream dose in the experiment is double what was intended — and the effect size observations will be correspondingly misleading.

This guide provides a systematic reference for calculating peptide concentrations when reconstituting with bacteriostatic water, covering the core math, unit conversions, and worked examples for several commonly researched peptide compounds. These principles apply universally regardless of which specific peptide is being reconstituted.

The Basic Concentration Formula

The fundamental relationship governing peptide solution concentration is straightforward:

Concentration (mg/mL) = Mass of Peptide (mg) ÷ Volume of Solvent Added (mL)

This formula assumes complete dissolution of the peptide, which is a valid assumption for the vast majority of lyophilized research peptides reconstituted in an appropriate solvent under proper conditions. The mass of peptide is the amount present in the vial (stated on the vial label or COA), and the volume is the amount of BAC water added by the researcher.

Inverting the Calculation: How Much BAC Water to Add

Researchers often work backwards from a desired final concentration to determine how much BAC water to add:

Volume of BAC Water (mL) = Mass of Peptide (mg) ÷ Desired Concentration (mg/mL)

Example: You have a 5 mg vial of BPC-157 and want a 2 mg/mL solution. Volume = 5 mg ÷ 2 mg/mL = 2.5 mL BAC water

Unit Conversions for Peptide Research

Research protocols frequently require moving between different units of mass and concentration. The following conversions are the most commonly encountered in peptide research work:

Mass Units

1 gram (g) = 1,000 milligrams (mg)

1 milligram (mg) = 1,000 micrograms (mcg or μg)

1 microgram (mcg) = 1,000 nanograms (ng)

Volume Units

1 milliliter (mL) = 1 cubic centimeter (cc) = 1,000 microliters (μL)

0.1 mL = 100 μL

0.01 mL = 10 μL

Concentration Unit Conversions

1 mg/mL = 1,000 mcg/mL = 1 μg/μL

0.1 mg/mL = 100 mcg/mL

0.01 mg/mL = 10 mcg/mL

IU Equivalents for Growth Hormone Peptides

Some growth hormone secretagogue research protocols express quantities in International Units (IU) rather than mass units. The IU is an activity-based unit, and the conversion factor varies by compound. For human growth hormone (rhGH) reference purposes, the WHO standard is approximately 3 IU per mg. Growth hormone-releasing peptides (GHRPs) and growth hormone-releasing hormones (GHRHs) used in research are not typically expressed in IU — their research doses are expressed in mass units (mcg or mg). When a research protocol cites IU for a compound like sermorelin or ipamorelin, verify the specific conversion factor being used, as this varies by source and context.

The Dilution Formula: C₁V₁ = C₂V₂

Once a stock solution is prepared, researchers routinely need to prepare working solutions at lower concentrations. The dilution equation is:

C₁V₁ = C₂V₂

Where:

C₁ = concentration of starting stock solution

V₁ = volume of stock solution to use

C₂ = desired final concentration

V₂ = total final volume of working solution

Example: Stock = 2 mg/mL. Need 0.1 mg/mL working solution in a total volume of 1 mL. (2 mg/mL)(V₁) = (0.1 mg/mL)(1 mL) V₁ = 0.05 mL = 50 μL of stock, diluted to 1 mL total with BAC water.

Worked Example 1: Semaglutide Reconstitution

Semaglutide is a 4,113.58 Da GLP-1 receptor agonist analog commonly supplied in 2 mg, 5 mg, or 10 mg vials for research purposes. Due to its molecular complexity and sensitivity to agitation, careful reconstitution is important. Full protocol details are available in our semaglutide and tirzepatide reconstitution guide and the semaglutide reconstitution guide.

Scenario: 5 mg semaglutide vial. Target stock concentration: 1 mg/mL.

Volume of BAC water = 5 mg ÷ 1 mg/mL = 5 mL

Resulting stock: 5 mg / 5 mL = 1 mg/mL = 1,000 mcg/mL

To aliquot a 500 mcg research dose from this stock: 500 mcg ÷ 1,000 mcg/mL = 0.5 mL (500 μL)

Alternative scenario: Same 5 mg vial, target 2 mg/mL concentration.

Volume of BAC water = 5 mg ÷ 2 mg/mL = 2.5 mL

To aliquot a 500 mcg dose: 500 mcg ÷ 2,000 mcg/mL = 0.25 mL (250 μL)

Worked Example 2: BPC-157 Reconstitution

BPC-157 (Body Protection Compound 157) is a 15-amino acid peptide (MW 1,419.53 Da) commonly supplied in 5 mg vials. Research protocols for BPC-157 often involve relatively small volume aliquots, making a moderately concentrated stock solution practical.

Scenario: 5 mg BPC-157 vial. Target stock: 500 mcg/mL (= 0.5 mg/mL).

Researchers looking for a broader overview of this compound can refer to the Complete Guide to BAC Water for Peptide Research, which covers the full research landscape in detail.

Volume of BAC water = 5 mg ÷ 0.5 mg/mL = 10 mL

Stock yields: 10 mL × 500 mcg/mL = 5,000 mcg total = 5 mg. Confirmed.

To prepare a working solution at 250 mcg/mL from this stock (2x dilution): 1 part stock + 1 part BAC water = 2 parts total. Final concentration: 250 mcg/mL.

More details on BPC-157 research are available in the BPC-157 mechanism of action research overview.

Worked Example 3: CJC-1295 No DAC Reconstitution

CJC-1295 No DAC (also called Modified GRF 1-29) is a 30-amino acid GHRH analog (MW 3,367.97 Da) commonly supplied in 2 mg vials. It is frequently combined with ipamorelin in research stacks. Research on this combination is reviewed in our ipamorelin/CJC-1295 combination research article.

Scenario: 2 mg CJC-1295 No DAC vial. Target stock: 1 mg/mL.

Volume of BAC water = 2 mg ÷ 1 mg/mL = 2 mL

Stock: 2 mg / 2 mL = 1 mg/mL = 1,000 mcg/mL

To aliquot a 100 mcg research dose: 100 mcg ÷ 1,000 mcg/mL = 0.1 mL (100 μL)

Concentration Calculation Reference Table

The table below provides pre-calculated reconstitution volumes and resulting concentrations for common peptide vial sizes. Use this as a quick reference when preparing stock solutions.

2 mg

1.0 mL

2.0 mg/mL

2,000 mcg/mL

50 μL

125 μL

250 μL

2.0 mL

1.0 mg/mL

1,000 mcg/mL

100 μL

500 μL

5 mg

5.0 mg/mL

5,000 mcg/mL

20 μL

2.5 mL

5.0 mL

10.0 mL

0.5 mg/mL

500 mcg/mL

200 μL

1,000 μL (1 mL)

10 mg

Selecting a Practical Stock Concentration

The choice of stock concentration involves a tradeoff between two competing considerations:

Higher stock concentrations (e.g., 5 mg/mL) require smaller draw volumes for each experimental dose, which can be challenging to measure accurately with standard laboratory syringes. Volumes below 10–20 μL introduce meaningful pipetting error.

Lower stock concentrations (e.g., 0.5 mg/mL) require adding more BAC water to the vial, which means the vial may be accessed more times or the solution volume may be impractically large for the vial size. Very dilute solutions also raise the risk of adsorption losses to the vial walls and syringe surfaces — a concern particularly for small peptides at very low concentrations.

A practical middle ground for most research peptides is a stock concentration of 1–2 mg/mL, yielding aliquot volumes in the 100–500 μL range for typical research doses. This range is easily and accurately handled with standard 1 mL syringes.

Calculating Molar Concentration (Optional)

Some research protocols, particularly receptor binding assays and cell-based studies, express concentrations in molar units (molarity, M) rather than mass-per-volume. The conversion requires knowing the molecular weight of the peptide:

Molar concentration (M) = [Mass concentration (g/L)] ÷ [Molecular weight (g/mol)]

Example for BPC-157 (MW = 1,419.53 g/mol) at 0.5 mg/mL:

0.5 mg/mL = 0.5 g/L

Molar concentration = 0.5 ÷ 1,419.53 = 0.000352 mol/L = 352 μM (micromolar)

BPC-157

1,419.53

704.5 μM

70.5 μM

Semaglutide

4,113.58

243.1 μM

24.3 μM

CJC-1295 No DAC

3,367.97

296.9 μM

29.7 μM

Ipamorelin

711.87

1,405 μM

140.5 μM

TB-500 (Thymosin β4)

4,981.49

200.7 μM

20.1 μM

GHK-Cu

340.38

2,938 μM

293.8 μM

Sermorelin

3,357.93

297.8 μM

29.8 μM

Accounting for Peptide Purity in Calculations

Lyophilized research peptides are not always 100% pure peptide by mass. The stated purity (e.g., ≥98%) refers to the peptide content relative to impurities, but the vial may also contain residual water, counter-ions from salt forms (e.g., trifluoroacetate from HPLC purification), and lyophilization excipients. This means that a vial labeled as "5 mg" may contain slightly less than 5 mg of pure peptide, depending on purity and residual moisture content.

For most research applications, this difference is within the acceptable margin of error, and researchers use the labeled mass as the basis for calculations. For highly quantitative research requiring precise molar concentrations — such as receptor binding affinity studies — the actual peptide content should be verified against the COA, and calculations should account for purity. For example, a 5 mg vial at 98% purity contains approximately 4.9 mg of active peptide.

For a deeper discussion of purity documentation and COA verification, see our article on understanding COAs for research peptides and the guide on semaglutide purity and quality control.

Syringe and Measurement Accuracy

Accurate concentration preparation depends not only on calculation but on accurate measurement of the BAC water volume added. For volumes above 0.5 mL, a standard 1 mL or 3 mL syringe provides adequate accuracy. For volumes between 0.1 and 0.5 mL, a 1 mL syringe with fine graduation markings is appropriate. For volumes below 0.1 mL (100 μL), a calibrated micropipette or an insulin syringe with appropriate graduation is recommended.

A common pitfall is using a large syringe (e.g., 5 mL or 10 mL) to add small volumes of BAC water — the graduation spacing on larger syringes makes precise small-volume measurements prone to error. Match the syringe size to the volume being measured.

Frequently Asked Questions

What is the simplest way to calculate how much BAC water to add to a peptide vial?

Divide the peptide mass (in mg) by your desired final concentration (in mg/mL). The result is the volume of BAC water to add in mL. For example: 5 mg peptide ÷ 2 mg/mL target = 2.5 mL BAC water.

How do I convert mcg to mg for calculation purposes?

Divide the number of micrograms by 1,000 to get milligrams. So 500 mcg = 0.5 mg, and 250 mcg = 0.25 mg. When working with stock concentrations in mg/mL, it is often easier to convert your target dose to mg first, then calculate the volume using the stock concentration.

My peptide vial says 5,000 mcg — is that the same as 5 mg?

Yes. 5,000 micrograms = 5 milligrams. Peptide vials are sometimes labeled in mcg rather than mg, particularly for lower-mass compounds. The math is identical — just convert to a consistent unit before calculating.

How do I prepare a 1:10 dilution of my stock solution?

Combine 1 part stock solution with 9 parts BAC water. For example, 100 μL stock + 900 μL BAC water = 1,000 μL (1 mL) total volume. The resulting concentration is one-tenth of the stock. A 1 mg/mL stock diluted 1:10 yields a 0.1 mg/mL working solution.

Does the molecular weight of a peptide affect how I calculate the concentration for mass-based dosing?

No. For mass-based dosing (mg/mL, mcg/mL), molecular weight is irrelevant — you are working with mass, not moles. Molecular weight only becomes relevant when converting to molar concentration (μM, nM) for assays that require it, such as receptor binding studies.

How precise do my BAC water measurements need to be?

For most research applications, measurements should be accurate to within 2–5%. A 1 mL syringe with 0.01 mL graduations provides adequate precision for volumes between 0.1 and 1 mL. For very small volumes (below 50 μL), use a calibrated micropipette to minimize error. The largest source of concentration error in practice is usually syringe measurement, not calculation.

Peer-Reviewed Citations

Siriwardena D, Sherwood MB, Dodson PM, et al. "A comparison of the short term intraocular pressure lowering effects of posterior sub-tenon triamcinolone and rimexolone 1% in patients with clinically significant diabetic macular oedema." British Journal of Ophthalmology. 2002;86(1):11-16.

Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. "Stability of protein pharmaceuticals: an update." Pharmaceutical Research. 2010;27(4):544-575. doi:10.1007/s11095-009-0045-6

Wang W, Singh S, Zeng DL, King K, Nema S. "Antibody structure, instability, and formulation." Journal of Pharmaceutical Sciences. 2007;96(1):1-26. doi:10.1002/jps.20727

Zbacnik TJ, Holcomb RE, Katayama DS, et al. "Role of buffers in protein formulations." Journal of Pharmaceutical Sciences. 2017;106(3):713-733.

United States Pharmacopeia. "<1> Injections and Implanted Drug Products." USP–NF. Current edition.

Final Disclaimer: All compounds discussed are research chemicals not approved by the FDA for human or veterinary use. All content here is for scientific and educational reference only. Palmetto Peptides sells these products exclusively for in vitro and preclinical laboratory research.

Authored by the Palmetto Peptides Research Team | Last Updated: May 14, 2026

Related Research

BAC Water Contamination Prevention in Peptide Research: Lab Safety and Handling Guide

Using BAC Water with Semaglutide and Tirzepatide: Research Reconstitution Guide

BAC Water Storage and Shelf Life: Research Lab Best Practices